GuidelineThe European respiratory journal2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.
3 registry-linked trialsOpen access · bronzeAbstract readPractice Guideline
In one paragraph
Guideline in The European respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 537 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
537citing papers in PubMed, 3 pooled it
52.9field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Drug Exposure and Minimum Inhibitory Concentration in the Treatment of Mycobacterium Avium Complex Lung Disease: a Prospective Observational Cohort Study
Pharmacokinetic Study of Minocycline in Patients With Pulmonary Nontuberculous Mycobacterial Disease
Association of Nutrition and T Cell Immune Activity With Disease Progression in Nontuberculous Mycobacterial Pulmonary Disease
Who cites it
537 citing papers in PubMed, 3 syntheses or guidelines pooled it, 834 citations in OpenAlex.
- Comparative evaluation of molecular technologies for the identification of prevalent non-tuberculous mycobacteria in pulmonary infections: a systematic review and meta-analysis.Annals of medicine · 2026Pooled it
- Management of Adult Bronchiectasis: Consensus-Based Guidelines of the German Respiratory Society.Respiration; international review of thoracic diseases · 2026Guideline
- A systematic review of tetracyclines for nontuberculous mycobacteria: focus on rapidly growing mycobacteria.European respiratory review : an official journal of the European Respiratory Society · 2025Pooled it
- Association Between Low-Dose Ethambutol Therapy and Optic Neuropathy inOpen forum infectious diseases · 2026Trial
- Intermittent versus Daily Therapy for NoncavitaryAnnals of the American Thoracic Society · 2025Trial
- Treatment Outcomes ofOpen forum infectious diseases · 2025Trial
- Clinical impact of chronic pulmonary aspergillosis in patients with pulmonary nontuberculous mycobacterial disease and colonization: a multicentre prospective cohort study.Annals of medicine · 2026Article
- Mediastinal lymphadenitis caused by Mycobacterium avium complex in children: a rare case of airway compression.European journal of pediatrics · 2026Article
- Post-Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management.MedComm · 2026Review
- Mycobacterium intracellulare M.i.198-A Promising Strain for Studying Pathogenesis of Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD).Microbiology and immunology · 2026Review
- A review of tigecycline resistance in nontuberculous mycobacteria.Molecular biology reports · 2026Review
- Epidemiologic trends and mortality in nontuberculous mycobacterial lung disease: a nationwide cohort study in Taiwan (2011-2020).Journal of global health · 2026Article
- Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Tuberculosis: A Retrospective Study on Clinical Features and a Diagnostic Model.Journal of clinical medicine · 2026Article
- Metagenomic next-generation sequencing for tuberculosis diagnosis: enhanced performance and cost-effectiveness.Microbiology spectrum · 2026Observational
- Robotic-Assisted Bronchoscopy and Pulmonary Nodules Due to Atypical Infections in Coccidioidomycosis Endemic Area.CHEST pulmonary · 2026Article
- Mycobacterium Abscessus Infection after Breast Augmentation: Case Reports and Literature Review.Aesthetic plastic surgery · 2026Review
- Nontuberculous mycobacterial pulmonary disease and lung cancer: a retrospective case series.Journal of thoracic disease · 2026Article
- Prevalence and outcomes of pleuroparenchymal fibroelastosis in patients with non-tuberculous mycobacterial pulmonary disease: a French retrospective cohort study.Journal of thoracic disease · 2026Article
- Temperature and pH growth preferences predict the pathogenicity and environmental distributions of nontuberculous mycobacteria.mSystems · 2026Article
- Pulmonary Nontuberculous Mycobacterial Disease in a Tuberculosis-Endemic Setting: Two Cases Illustrating Diagnostic Pitfalls.Reports (MDPI) · 2026Article
477 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 16 institutions in 9 countries.
Charles L DaleyDept of Medicine, National Jewish Health, Denver, CO, USA.
Jonathan M IaccarinoPulmonary Center, Boston University School of Medicine, Boston, MA, USA.
Christoph LangeDivision of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
Emmanuelle CambauNational Reference Center for Mycobacteria and Antimycobacterial Resistance, APHP -Hôpital Lariboisière, Bacteriology; Inserm, University Paris Diderot, IAME UMR1137, Paris, France.
Richard J WallaceMycobacteria/Nocardia Laboratory, Dept of Microbiology, The University of Texas Health Science Center, Tyler, TX, USA.
Claire AndrejakRespiratory and Intensive Care Unit, University Hospital Amiens, Amiens, France.
Erik C BöttgerInstitute of Medical Microbiology, National Reference Center for Mycobacteria, University of Zurich, Zurich, Switzerland.
Jan BrozekDept of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre, Hamilton, ON, Canada.ORCID 0000-0002-3122-0773
David E GriffithPulmonary Infectious Disease Section, University of Texas Health Science Center, Tyler, TX, USA.
Lorenzo GuglielmettiNational Reference Center for Mycobacteria and Antimycobacterial Resistance, APHP -Hôpital Lariboisière, Bacteriology; Inserm, University Paris Diderot, IAME UMR1137, Paris, France.ORCID 0000-0003-0886-9635
Gwen A HuittDept of Medicine, National Jewish Health, Denver, CO, USA.ORCID 0000-0003-0398-8109
Shandra L KnightLibrary and Knowledge Services, National Jewish Health, Denver, CO, USA.
Philip LeitmanNTM Info and Research, Miami, FL, USA.
Theodore K MarrasDept of Medicine, University of Toronto and University Health Network, Toronto, ON, Canada.
Kenneth N OlivierPulmonary Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA.ORCID 0000-0001-8200-255X
Miguel SantinService of Infectious Diseases, Bellvitge University Hospital-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-8474-3543
Jason E StoutDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0002-6698-8176
Enrico TortoliEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-5512-704X
Jakko van IngenRadboud Center for Infectious Diseases, Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-0581-2003
Dirk WagnerDivision of Infectious Diseases, Dept of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-3271-5815
Kevin L WinthropDivisions of Infectious Diseases, Schools of Public Health and Medicine, Oregon Health and Science University, Portland, OR, USA.
National Jewish Health · USInserm · FRThe University of Texas Health Science Center at Tyler · USBellvitge University Hospital · ESBoston University · USCentre Hospitalier Universitaire Amiens-Picardie · FRDuke Medical Center · USKarolinska Institutet · SEMcMaster University Medical Centre · CANational Heart Lung and Blood Institute · USOregon Health & Science University · USRadboud University Nijmegen · NLUniversity Health Network · CAUniversity of Freiburg · DEUniversity of Zurich · CHVita-Salute San Raffaele University · IT
Funding
Bronchiectasis and chronic airway infectionZIAHL006200 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI FENNELLY, KEVIN · 2015 to 2025
$25.1MIntramural NIH HHS Z99 HL999999Intramural NIH HHS ZIA HL006200
Abstract
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as
Indexed as
Mycobacterium abscessusMycobacterium Infections, NontuberculousMycobacterium kansasiiAdultHumansMycobacterium avium ComplexNontuberculous Mycobacteria
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.